116
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Modulated electro-hyperthermia-enhanced liposomal drug uptake by cancer cells

, , , , , , & show all
Pages 1269-1279 | Published online: 18 Feb 2019

References

  • AndocsGRennerHBaloghLFonyadLJakabCSzaszAStrong synergy of heat and modulated electromagnetic field in tumor cell killingStrahlenther Onkol2009185212012619240999
  • SzaszAVinczeGSzaszOSzaszNAn energy analysis of extracellular hyperthermiaElectromagn Biol Med2003222–3103115
  • AndocsGSzaszOSzaszAOncothermia treatment of cancer: from the laboratory to clinicElectromagn Biol Med200928214816519811397
  • SzaszASzaszNSzaszOOncothermia: a new kind of oncologic hyperthermia Oncothermia: Principles and PracticesNetherlandsSpringer2010173392
  • SzaszAVinczeGDose concept of oncological hyperthermia: heat-equation considering the cell destructionJ Can Res Ther200624171181
  • HegyiGSzigetiGPSzászAHyperthermia versus Oncothermia: cellular effects in complementary cancer therapyEvid Based Complement Alternat Med201320134112
  • Gadaleta-CaldarolaGInfusinoSGaliseISorafenib and locoregional deep electro-hyperthermia in advanced hepatocellular carcinoma: a phase II studyOncol Lett2014841783178725202410
  • FiorentiniGGiovanisPRossiSA phase II clinical study on relapsed malignant gliomas treated with electro-hyperthermiaIn Vivo2006206A72172417203754
  • SzaszACurrent status of oncothermia therapy for lung cancerKorean J Thorac Cardiovasc Surg2014472779324782955
  • AndocsGSzaszOSzaszAOncothermia treatment of cancer: from the laboratory to clinicElectromagn Biol Med200928214816519811397
  • HegyiGSzigetiGPSzászAHyperthermia versus Oncothermia: cellular effects in complementary cancer therapyEvid Based Complement Alternat Med201320134112
  • YangKLHuangCCChiMSIn vitro comparison of conventional hyperthermia and modulated electro-hyperthermiaOncotarget2016751840828409227556507
  • AndocsGRehmanMUZhaoQ-LPappEKondoTSzaszANano-heating without artificial nanoparticles Part II. Experimental support of the Nanoheating concept of the modulated Electro-Hyperthermia method, using U937 cell suspension modelBiology and Medicine20150704247
  • SzaszAChallenges and solutions in oncological hyperthermiaThermal Medicine2013291123
  • ZhaoMDingXFShenJYZhangXPDingXWXuBUse of liposomal doxorubicin for adjuvant chemotherapy of breast cancer in clinical practiceJ Zhejiang Univ Sci B2017181152628070993
  • GabizonAAPatilYLa-BeckNMNew insights and evolving role of pegylated liposomal doxorubicin in cancer therapyDrug Resist Updat2016299010627912846
  • DichevaBMKoningGATargeted thermosensitive liposomes: an attractive novel approach for increased drug delivery to solid tumorsExpert Opin Drug Deliv20141118310024320104
  • ShafeiAEl-BaklyWSobhyAA review on the efficacy and toxicity of different doxorubicin nanoparticles for targeted therapy in metastatic breast cancerBiomed Pharmacother2017951209121828931213
  • AndocsGRehmanMUZhaoQLTabuchiYKanamoriMKondoTComparison of biological effects of modulated electro-hyperthermia and conventional heat treatment in human lymphoma U937 cellsCell Death Discov2016211603927551529
  • ChangHIYehMKClinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacyInt J Nanomedicine20127496022275822
  • ChangCHStabinMGChangYJComparative dosimetric evaluation of nanotargeted (188)Re-(DXR)-liposome for internal radiotherapyCancer Biother Radiopharm200823674975819111045
  • KouLSunJZhaiYHeZThe endocytosis and intracellular fate of nanomedicines: implication for rational designAsian J Pharmaceut Health Sci201381110
  • MayorSPaganoREPathways of clathrin-independent endocytosisNat Rev Mol Cell Biol20078860361217609668
  • KongGAnyarambhatlaGPetrosWPEfficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug releaseCancer Res200060246950695711156395
  • HeidarliEDadashzadehSHaeriAState of the art of Stimuli-Responsive liposomes for cancer therapyIran J Pharm Res20171641273130429552041
  • LiLTen HagenTLHaeriAA novel two-step mild hyperthermia for advanced liposomal chemotherapyJ Control Release201417420220824269966
  • LiLTen HagenTLBolkesteinMImproved intratumoral nanoparticle extravasation and penetration by mild hyperthermiaJ Control Release2013167213013723391444
  • TsangYWHuangCCYangKLImproving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapyBMC Cancer201515170826472466
  • MeggyeshaziNAndocsGBaloghLDNA fragmentation and caspase-independent programmed cell death by modulated electrohyperthermiaStrahlenther Onkol2014190981582224562547
  • MerlinJLMarchalSRamacciCNotterDVigneronCAntiproliferative activity of thermosensitive liposome-encapsulated doxorubicin combined with 43 degrees C hyperthermia in sensitive and multidrug-resistant MCF-7 cellsEur J Cancer199329A16226422688110497
  • VujaskovicZKimDWJonesEA phase I/II study of neoadjuvant liposomal doxorubicin, paclitaxel, and hyperthermia in locally advanced breast cancerInt J Hyperthermia201026551452120377362
  • YangHZhaoJWuCYeCZouDWangSFacile synthesis of colloidal stable MoS2 nanoparticles for combined tumor therapyChem Eng J2018351548558
  • ZhaoJXiePYeCOutside-in synthesis of mesoporous silica/molybdenum disulfide nanoparticles for antitumor applicationChem Eng J2018351157168
  • StaruchRMHynynenKChopraRHyperthermia-mediated doxorubicin release from thermosensitive liposomes using MR-HIFU: therapeutic effect in rabbit VX2 tumoursInt J Hyperthermia201531211813325582131
  • LyonPCGriffithsLFLeeJClinical trial protocol for TARDOX: a phase I study to investigate the feasibility of targeted release of lysothermosensitive liposomal doxorubicin (ThermoDox®) using focused ultrasound in patients with liver tumoursJ Ther Ultrasound2017512829118984